Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report.

PURPOSE: This pilot study was designed to describe the technical details and to present the preliminary outcome of autologous matrix-induced chondrogenesis (AMIC) combined with platelet-rich plasma gel, the so called AMIC plus technique, for the treatment of patellar cartilage defects in the knee. METHODS: The AMIC plus technique was used for the treatment of (osteo) chondral patellar lesions in the knee. The surgical technique is extensively described. Five patients were clinically prospectively evaluated during 2 years. MRI data were analysed based on the original MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) and modified MOCART scoring system. RESULTS: A clinical improvement became apparent after 24 months of follow-up. Both MOCART scoring systems revealed no significant deterioration or improvement of the repair tissue between one and 2 years of follow-up. However, all cases showed subchondral lamina and bone changes. The formation of intralesional osteophytes was observed in 3 of the 5 patients during the 2 years of follow-up. CONCLUSIONS: AMIC plus is feasible for the treatment of symptomatic patellar cartilage defects and resulted in a clinical improvement in all patients. The favourable clinical outcome of the AMIC plus technique was not confirmed by the MRI findings. LEVEL OF EVIDENCE: IV.

Novel dinuclear luminescent compounds based on iridium(III) cyclometalated chromophores and containing bridging ligands with ester-linked chelating sites.

The syntheses and study of the spectroscopic, redox, and photophysical properties of a new set of species based on Ir(III) cyclometalated building blocks are reported. This set includes three dinuclear complexes, that is, the symmetric (with respect to the bridging ligand) diiridium species [(ppy)(2)Ir(mu-L-OC(O)-C(O)O-L)Ir(ppy)(2)][PF(6)](2) (5; ppy = 2-phenylpyridine anion; L-OC(O)-C(O)O-L = bis[4-(6'-phenyl-2,2'-bipyridine-4'-yl)phenyl]-benzene-1,4-dicarboxylate), the asymmetric diiridium species [(ppy)(2)Ir(mu-L-OC(O)-L)Ir(ppy)(2)][PF(6)](2) (3; L-OC(O)-L = 4-([(6'-phenyl-2,2'-bipyridine-4'-yl)benzoyloxy]phenyl)-6'-phenyl-2,2'-bipyridine), and the mixed-metal Ir-Re species [(ppy)(2)Ir(mu-L-OC(O)-L)Re(CO)(3)Br][PF(6)] (4). Syntheses, characterization, and spectroscopic, photophysical, and redox properties of the model mononuclear compounds [Ir(ppy)(2)(L-OC(O)-L)][PF(6)] (2) and [Re(CO)(3)(L-COOH)Br] (6; L-COOH = 4'-(4-carboxyphenyl)-6'-phenyl-2,2'-bipyridine) are also reported, together with the syntheses of the new bridging ligands L-OC(O)-L and L-OC(O)-C(O)O-L. The absorption spectra of all the complexes are dominated by intense spin-allowed ligand-centered (LC) bands and by moderately intense spin-allowed metal-to-ligand charge-transfer (MLCT) bands. Spin-forbidden MLCT absorption bands are also visible as low-energy tails at around 470 nm for all the complexes. All the new species exhibit metal-based irreversible oxidation and bipyridine-based reversible reduction processes in the potential window investigated (between +1.80 and -1.70 V vs SCE). The redox behavior indicates that the metal-based orbitals are only weakly interacting in dinuclear systems, whereas the two chelating halves of the bridging ligands exhibit noticeable electronic interactions. All the complexes are luminescent both at 77 K and at room temperature, with emission originating from triplet MLCT states. The luminescence properties are temperature- and solvent-dependent, in accord with general theories: emission lifetimes and quantum yields increase on passing from acetonitrile to dichloromethane fluid solution and from room-temperature fluid solution to 77 K rigid matrix. In the dinuclear mixed-chromophore species 3 and 4, photoinduced energy transfer across the ester-linked bridging ligands seems to occur with low efficiency.

Structural studies on layered alkylpyridinium iodopalladate networks.

The reaction of alkylpyridinium (CnH2n + 1NC5H5, hereafter Cn-Py) iodide salts in aqueous acetonitrile with a preformed palladium iodide precursor afforded two different types of organic-inorganic phases depending on the molar ratio. A 2:1 ratio yielded the phase [Cn-Py]2[PdI4] (3, n = 14, 16), which crystallized in the triclinic crystal system. The X-ray crystal structure of 3, (n = 14), refined in the space group P1 (a = 8.918(3) A, b = 9.894(3) A, c = 29.062(12) A, alpha = 93.51(3) degrees, beta = 94.17(3) degrees, gamma = 115.60(3) degrees, and Z = 2), consists of interdigitated bilayers with a basal spacing of 29.0 A. The aliphatic chains of the cations, which run almost parallel to the stacking direction, are fully stretched between polar planes built on isolated [PdI4]2- anions and cation headgroups. Changing the organic cation to palladium ratio to 1:1 led to a new phase [Cn-Py]2[Pd2I6] (4, n = 14, 16), which crystallizes in the triclinic P1 space group (a = 9.399(4) A, b = 14.264(6) A, c = 29.415(13) A, alpha = 92.11(4) degrees, beta = 90.07(4) degrees, gamma = 104.53(3) degrees, Z = 3 for 4(n = 14); a = 9.417(2) A, b = 14.215(3) A, c = 31.552(6) A, alpha = 87.96(3) degrees, beta = 87.63(3) degrees, gamma = 75.67(3) degrees, Z = 3 for 4(n = 16)). The layered structure is basically of a continuously interdigitated single-layer type, with a bilayer sublattice superimposed. Isolated [Pd2I6]2- anions contribute to the inorganic planes. A high degree of interdigitation and tilting of the aliphatic chains lead to basal spacings of 29.4 and 31.5 A for 4(n = 14) and 4(n = 16), respectively. The [Cn-Py]2[PdI4] and [Cn-Py]2[Pd2I6] phases were characterized by thermal analysis. Mesomorphic behavior was observed only for 3(n = 16), which was confirmed by variable-temperature powder XRD and optical microscopy.